The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Cancer Anorexia-Cachexia Syndrome (CACS) Market Change Between 2026 And 2030?
The cancer biopsy market has seen swift growth in recent years. It is anticipated to expand from $28.52 billion in 2025 to $32.41 billion in 2026, achieving a compound annual growth rate (CAGR) of 13.6%. This historical development can be ascribed to several factors, including the increasing global occurrence of cancer, the proliferation of diagnostic imaging centers, the integration of tissue biopsy as a standard diagnostic procedure, the expansion of pathology laboratory networks, and enhancements in biopsy device technologies.
The cancer biopsy market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $53.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.3%. This growth during the projected timeframe is attributable to a heightened demand for precision oncology diagnostics, increased uptake of liquid biopsy testing, the broadening of personalized cancer treatment strategies, expanding investments in molecular diagnostics, and a sharpened emphasis on early-stage cancer screening. Key trends anticipated for this period encompass the growing integration of liquid biopsy methods, an uptick in the utilization of image-guided biopsy procedures, an expanding incorporation of molecular pathology testing, the development of minimally invasive biopsy devices, and an intensified focus on identifying cancer early.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21125&type=smp
What Important Drivers Are Powering The Cancer Anorexia-Cachexia Syndrome (CACS) Market Growth?
The rising incidence of cancer is predicted to fuel the expansion of the cancer biopsy market moving ahead. Cancer is a complex assortment of diseases defined by the abnormal proliferation and dissemination of cells. This rise in cancer cases can be attributed to multiple elements, such as evolving lifestyles and urbanization, environmental contamination, tobacco and alcohol consumption, and differences in healthcare access and awareness. A cancer biopsy serves to diagnose and evaluate the cancer’s type, stage, and spread through the extraction and analysis of tissue or cells from a suspicious zone. For instance, in February 2024, the World Health Organization, an intergovernmental organization located in Switzerland, projected that by 2050, more than 35 million new cancer cases would arise, marking a 77% increase over the estimated 20 million cases in 2022. Thus, the escalating prevalence of cancer acts as a significant impetus for the cancer biopsy market.
What Are The Major Segment Categories Within The Cancer Anorexia-Cachexia Syndrome (CACS) Market?
The cancer anorexia-cachexia syndrome (cacs) market covered in this report is segmented –
1) By Indication: Weight Loss Prevention, Appetite Loss, Muscle Wasting, Inflammation, Other Indications
2) By Therapeutics: Progestogen, Corticosteroid, Combination Therapy, Other Therapeutics
3) By Mechanism Of Action: Appetite Stimulants, Anti-inflammatory Agents, Hormone Therapies, Cannabinoids, Other Mechanism Of Actions
4) By Route of Administration: Oral, Intravenous, Subcutaneous, Other Routes of Administration
5) By Application: Hospitals, Clinics, Home Care
Subsegments:
1) By Weight Loss Prevention: Nutritional Supplements, Metabolic Modulators
2) By Appetite Loss: Appetite Stimulants, Ghrelin Receptor Agonists
3) By Muscle Wasting: Anabolic Agents, Selective Androgen Receptor Modulators (SARMs)
4) By Inflammation: Anti-Inflammatory Drugs, Cytokine Inhibitors
5) By Other Indications: Combination Therapies, Supportive Care Interventions
What Trends Are Affecting The Growth Of The Cancer Anorexia-Cachexia Syndrome (CACS) Market?
Leading companies in the cancer biopsy market are actively developing liquid biopsy techniques. These advancements aim to enable non-invasive, early detection and monitoring of cancer, improve patient outcomes, and facilitate more personalized treatment approaches. Liquid biopsy is a sophisticated, non-invasive diagnostic method that identifies and analyzes genetic material from blood samples, including circulating tumor DNA (ctDNA), RNA, exosomes, and other biomarkers. For example, in May 2023, Labcorp, a US-based company specializing in cancer biopsy manufacturing, launched Labcorp Plasma Focus, a plasma-focused liquid biopsy designed to detect cancer-related biomarkers. The Plasma Focus test examines circulating cell-free DNA (cfDNA) released from tumor cells into the bloodstream, capable of constructing a genomic profile of the patient’s tumor and identifying mutations across 33 genes linked to various cancers, such as non-small cell lung cancer, colorectal cancer, breast cancer, esophageal cancer, and melanoma.
Which Firms Are Competing In The Cancer Anorexia-Cachexia Syndrome (CACS) Market?
Major companies operating in the cancer anorexia-cachexia syndrome (cacs) market are Pfizer Inc., Merck & Co. Inc., Ono Pharmaceutical Co. Ltd., Mundipharma International Limited, Yuhan Corporation, Helsinn Healthcare SA, AVEO Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Larix Bioscience LLC, Aeterna Zentaris Inc., Artelo Biosciences Inc., Sapphire Therapeutics Inc., Endevica Bio, AAVogen Inc., Actimed Therapeutics Ltd., Aphios Corporation, Betula Pharmaceuticals AB, Cannabics Pharmaceuticals Inc., Creative Medical Technology Holdings Inc., Abreos Biosciences Inc.
Access The Complete Cancer Anorexia-Cachexia Syndrome (CACS) Market Report:
Which Geographic Region Represents The Largest Cancer Anorexia-Cachexia Syndrome (CACS) Market Share?
North America was the largest region in the cancer anorexia-cachexia (CACS) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer anorexia-cachexia syndrome (cacs) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Cancer Anorexia-Cachexia Syndrome (CACS) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=21125&type=smp
Browse Through More Reports Similar to the Global Cancer Anorexia-Cachexia Syndrome (CACS) Market 2026, By The Business Research Company
Anaphylaxis Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report
Vulvodynia Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/vulvodynia-treatment-global-market-report
Emphysema Treatment Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model